Business Development

Michael PrattMP 2010, MBA

Executive Director, Business Development
(617) 353-4569 button-linkedin

Mr. Pratt joined Boston University’s Office of Technology Development in May 2000. He worked in Technology Transfer, responsible for the transfer of technologies from the fields of physical, engineering, and computer sciences, as Director of the Office of Corporate Business Development, responsible for building long term partnerships with a special focus on technology development between Boston University/Boston Medical Center and industryand as Director of Translational Research & Corporate Relations, providing support to faculty that participate in translational research programs through proposal development, implementation of translational research, and facilitating collaboration with industry.  As Executive Director Business Development he leads a team of business development professionals across all technical fields to connect Boston University discoveries with commercial opportunities.

Prior to OTD, Mr. Pratt was the Global Support Manager at NESLAB Instruments, Inc. of Portsmouth New Hampshire. His duties included management of the Application Engineering and Technical Support departments, P&L responsibility for the field service operation, and maintaining relationships with their International Dealer network.

Mr. Pratt holds a Bachelor of Arts in Physics from Holy Cross College. He is a member of the Licensing Executives Society and the Association of University Technology Managers (AUTM).

Nelson Medeiros, Ph.D.

Director, Business Development, Medical Devices, Diagnostics, and Life Science Tools
(617) 353-4567 button-linkedin38be0ee

Nelson joined OTD’s business development group in March 2011 with a focus on medical devices and instrumentation.  He manages a portfolio of medical devices, life science tools, and diagnostics inventions from BU.   Prior to BU, Nelson spent 5 years at Fletcher Spaght, a boutique strategy consulting and venture capital firm with expertise in medical devices.  At Fletcher Spaght, Nelson outlined the commercialization strategy of early stage companies and emerging technologies and performed due diligence supporting acquisitions and venture capital investment.  In addition, Nelson has over 10 years of bench research experience in the neurosciences at the National Institute of Neurological Disorders and Stroke, Marine Biological Laboratory, and Yale University.

Nelson received his PhD in Neuroscience from Yale University and Bachelor of Arts in Biology and History from Brown University.

David Lough, Ph.D.

Director, Business Development, Life Sciencesimage copy
(617) 358-4550 button-linkedin

David joined OTD in July 2013, to manage the commercialization of discoveries and ideas in the life sciences, including therapeutics and diagnostics.  David has over 16 years of experience growing with start-up and early-stage therapeutics and molecular diagnostics companies, working in a variety of roles including R&D, technology development, customer support, business development, and alliance management.

As Director of Business Development & Alliance Management with Idera Pharmaceuticals, David was an active deal team member for Idera’s out-licensing partnerships in cancer therapeutics and vaccine adjuvants, worth $70 million upfront and $875 million potential total.  David started off his career working in a variety of scientific and management positions with the genetic analysis company Sequenom, Inc., including Manager of East Coast Operations. He worked closely with R&D, product development, bioinformatics, marketing, and Sequenom’s clients, to help improve the MassARRAY genotyping platform system and ready it for commercial launch.

David received his Ph.D. in BioOrganic Chemistry and B.Sc. in Environmental Chemistry from the University of Edinburgh, Scotland, and earned a Graduate Certificate in Intellectual Property from Northeastern University, Boston.   He is an inventor on seven US patents issued in a variety of technologies related to the analysis of nucleic acids.

Ana Lopes

Director, Business Development, Physical Sciences3a4ea32

Ana joined the Office of Technology Development at Boston University in May 2014. As Director of Business Development, she manages BU’s portfolio of Physical Sciences inventions with the mission to commercialize the university’s technologies, develop stronger university-industry relations as well as support BU’s entrepreneurial activities.

Prior to the OTD, Ana was a founding partner at a consulting company where she connected Brazilian technology based companies with Boston’s innovation ecosystem. Ana also worked as a Business Development Strategist at E Ink where she was responsible for developing strategies for new markets and applications for the company’s leading electronic paper display (EPD) technology. In addition, Ana has many years of experience with technology transfer, having worked at the Technology Licensing Office at the Massachusetts Institute of Technology (MIT). As a Technology Licensing Associate, she assisted with all aspects of technology commercialization from IP evaluation to strategy development and deal negotiations, with a focus on technologies in Clean Energy, Chemistry, Chemical Engineering and Materials.

Ana is a graduate from the University of Toronto where she earned an Honours Bachelor of Science in Astronomy and Physics and is currently pursuing her Master in Business Administration.